Table: begin end state 1 26 cytoplasmic 27 57 transmembrane 58 65 non-cytoplasmic 66 88 transmembrane 89 98 cytoplasmic 99 119 transmembrane 120 125 non-cytoplasmic 126 152 transmembrane 153 163 cytoplasmic 164 187 transmembrane 188 198 non-cytoplasmic 199 220 transmembrane 221 252 cytoplasmic 253 277 transmembrane 278 288 non-cytoplasmic 289 310 transmembrane 311 317 cytoplasmic 318 338 transmembrane 339 344 non-cytoplasmic 345 369 transmembrane 370 380 cytoplasmic 381 399 transmembrane 400 410 non-cytoplasmic 411 429 transmembrane 430 436 cytoplasmic
Input: >SMc01869 MTDATTSLSPQDGALHRQAVNSPARVLFASLVGTTIEFFDFYVYATAAVIIFPHLFFPAA DPTSAMLQSLATFSIAFFARPLGAVIFGHFGDRIGRKATLVAALMTMGISTVVIGLLPTY STIGVVAPLLLALCRFGQGLGLGGEWGGAVLLATENAPEGKRSWYAMFPQLGAPIGFILS AGTFLILGEVMSEEAFLAWGWRVPFIASVLLVIVGLYVRLKITETPEFQKAIDKHERVEV PVAAIFRSHKRSLVLGTFVALATFVLFYLMTVFSLSWGTTKLGYSREQFLLVQMTGVVFF GLMIPVSGILSDRFGRRLVLVLTTIGIGVFGLFMAPLLSSGLGGAFVFSIVGLGLMGLTY GPIGAALAAPFPTAVRYTGASMTFNLAGIFGASLAPYIATWLATNYSLGHVGYYLLAAAS ITLVCLLLSNEEEVSG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server